[Intracranial hemorrhage complicated by recurrent polymorphic ventricular torsade de pointes tachycardia]. 2003

Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
OddziaƂ Wewnetrzny, Szpitala Specjalistycznego im. Klimontowicza, Gorlice, Poland.

We present a case of a 65-year-old female admitted to the hospital due to severe intracranial hemorrhagia complicated by recurrences of polymorphic ventricular tachycardia of torsade de pointes type. ECG showed a marked prolongation of QT interval and giant U waves. The potassium level was 2.9 mmol/l and magnesium level - 0.6 mmol/l. Intravenous lidocaine and magnesium caused a complete supression of arrhythmia. Unfortunately, the patient died three days later due to cerebral damage and respiratory failure.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016171 Torsades de Pointes A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION. Torsade de Pointes,Pointes, Torsade de,Pointes, Torsades de,de Pointes, Torsade,de Pointes, Torsades
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
January 1984, Intensive care medicine,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
January 1984, Vutreshni bolesti,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
November 1995, Anesthesia and analgesia,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
April 1999, Anesthesia and analgesia,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
May 1983, Heart & lung : the journal of critical care,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
November 1979, Postgraduate medical journal,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
May 1992, The New England journal of medicine,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
April 1997, Orvosi hetilap,
Piotr Kukla, and Alicja Bromblik, and Danuta Malecka-Tomasik, and Teresa Slowiak-Lewinska
October 1981, Harefuah,
Copied contents to your clipboard!